openPR Logo
Press release

GLP-1 Receptor agonists Market Size, Share, Impressive Industry Growth, Analysis Report 2028

06-03-2022 10:24 AM CET | Health & Medicine

Press release from: Orion Market Research

GLP-1 receptor agonists market is anticipated to showcase a considerable CAGR during the forecast period. The increasing R&D and huge investment by the major market players for the development of new products along with the high prevalence of type 2 diabetic patients across the globe are the key factors responsible for the high growth of the GLP-1 receptor agonists market across the globe. GLP-1 receptor agonists are a category of antidiabetic agents that performs functioning of the glucagon-like peptide. GLP-1 is a natural incretin compound that influences the body functioning once they get released from the gut during digestion.

A full report of GLP-1 Receptor agonists Market is available at: https://www.omrglobal.com/industry-reports/glucagon-like-peptide-1-glp-1-receptor-agonists-market

The combination of GLP-1 receptors, GLP-1 agonists, and endogenous GLP-1 is capable to reduce blood glucose levels to facilitate Type 2 diabetes patients to reach glycemic control. The proper intake of the GLP-1 receptor agonists increases the glucose-dependent secretion of insulin from functioning beta cells. Moreover, its intake decreases the glucagon release after meals, decrease hepatic glucose production, delayed gastric emptying, suppress the appetite and promotes beta-cell proliferation. According to the International Diabetic Federation (IDF) in 2019, nearly 463 million adults (20-79 years) were living with diabetes across the globe and this figure is anticipated to reach 700 million by 2045.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/glucagon-like-peptide-1-glp-1-receptor-agonists-market

Diabetes is responsible for nearly $760 billion in health expenditure in 2019 that resembles 10% of total spending on adults for their health treatment. In 2019, 374 million people are observed to be at an increased risk of developing type 2 diabetes. The considerably high prevalence of this chronic disorder is creating the demand for the market growth of the GLP-1 receptor agonists. Bristol Mayer Squibb, Novo Nordisk A/S, Sanofi SA, Eli Lilly & Company, AstraZeneca PLC, and Merck & Co., Inc are the key players operating in the global GLP-receptor agonists market that are making hefty investments in the R&D of new drugs.
Moreover, these players are actively adopting other growth strategies such as mergers & acquisitions, strategic agreements, partnerships, and collaborations in order to remain competitive in the global GLP-1 receptor agonists market.
Recent Development in the market
In September 2019, the US FDA had approved Rybelsus (semaglutide) oral tablets prepared by the Novo Nordisk A/S, a pharmaceutical company to improve the control of blood sugar levels in adult patients with type 2 diabetes, along with diet and exercise. Rybelsus is the first GLP-1 receptor protein treatment approved for use in the US that does not need to be injected. GLP-1 drugs are non-insulin treatments for people with type 2 diabetes.

Global GLP-1 Receptor Agonists Market Segmentation

By Drug Type

• Exenatide
• Liraglutide
• Lixisenatide
• Dulaglutide

GLP-1 Receptor agonists Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AstraZeneca PLC
• Bristol Mayer Squibb, Co.
• Eli Lilly & Company
• Merck & Co., Inc.
• Novo Nordisk A/S
• Sanofi SA

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GLP-1 Receptor agonists Market Size, Share, Impressive Industry Growth, Analysis Report 2028 here

News-ID: 2644249 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Receptor

Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Market: Competitive Dyna …
Global Info Research offers a latest published report on Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in
DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologo …
DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2020 report by comprehensive insights of present scenario and growth prospects across DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action,
TRAIL Receptor 1 & Receptor 2 Agonist Pipeline Analysis 2020 Along with Research …
TRAIL Receptor 1 & Receptor 2 Agonist -Pipeline Insight, 2020: The report presents an in-depth assessment of TRAIL Receptor 1 & Receptor 2 Agonist including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for TRAIL Receptor 1 & Receptor 2 Agonist investments from 2020 till 2030 Major Key Players:AbbVie,
Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Recept …
Market Research Hub (MRH) has added a new report titled “Calcitonin Gene Related Peptide Type 1 Receptor, Pharmaceutical Pipeline Research Report” to its vast data repository. Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1
Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Rece …
"Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Directs, Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016, provides in depth analysis on Transient Receptor Potential Cation
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Recepto …
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H2 2016, provides in depth analysis on Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) targeted pipeline therapeutics. The report provides comprehensive information on the Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1), targeted therapeutics, complete with analysis by